Resverlogix Corp. (RVXCF) - OTCPK - Current
  • Life Sciences Report | Send Message 6 Apr

    "A lot of key opinion leaders are behind $RVXCF's drug candidate"- George Zavoico. Read more: http://ow.ly/10nh69
    Reply (1)
    • jmd1313 | Send Message 29 Apr
      : Who are these KOLs?
      • Life Sciences Report | Send Message 6 Apr

        How Three Companies Have Been Resurrected From Failed Clinical Trials: George Zavoico... $ABEO, $AST, $RVXCF http://seekingalpha.com/p/2weow
        Reply
          • Life Sciences Report | Send Message 17 Feb

            " $RVXCF's strategy is to start w/ the clinical trial, derive data & create value"-Marcel W. More: http://ow.ly/YrS8B
            Reply (1)
            • BiotechX | Send Message 27 Feb
              : It will take some time to see interim results but the stock is a bet and PhII data look good.
              • Life Sciences Report | Send Message 17 Feb

                Circling The Globe For Uncommon Biotech Opportunities: Van Leeuwenhoeck's Marcel... $ANOZF, $MDXHF, $RVXCF http://seekingalpha.com/p/2v67u
                Reply
                  • Bjarke Krysel Christensen | Send Message 28 Jan

                    Resverlogix: RVX-208 And The Epigenetics Of Age Related Diseases $RVXCF http://seekingalpha.com/a/290z0
                    Reply
                      • Joe_Retail | Send Message 24 Jan

                        $RVXCF Peer reviewed article on atherosclerosis-journal website: http://bit.ly/1PrkgXY
                        Reply
                          • Life Sciences Report | Send Message 20 Jan

                            "If $RVXCF is successful with RVX-208, there is a lot of upside left"- Alan Leong. Read more: http://ow.ly/Xl0Si
                            Reply
                              • Joe_Retail | Send Message 13 Jan

                                One, Two, Three Quiet Little Biotechs $TBIO, $RVXCF, $PPHM http://seekingalpha.com/p/2swtu
                                Reply
                                  • BiotechX | Send Message 9 Nov 2015

                                    The market sizes for which RVX-208 ($RVXCF) shows therapeutic promise are significant; for CVD alone, DB estimates that the residual risk...
                                    Reply (5)
                                  • View all 5 replies
                                    • BiotechX | Send Message 9 Nov 2015
                                      : ...the company's stock is currently undervalued and could trade in the range of $3.54 - $9.34 per share
                                    • BiotechX | Send Message 9 Nov 2015
                                      : Everything can be found here: http://yhoo.it/1NmCC5h
                                      • BiotechX | Send Message 3 Sep 2015

                                        Intruiging technology but overseen & undervalued if the PhIII is successful! I recommend reading the Life Sciences Report on $RVXCF.
                                        Reply
                                          Company Description
                                          Currently, there's no company description for RVXCF.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: Canada